Rheumatology

Chapter 35


Rheumatology






4 What other clues point to a diagnosis of osteoarthritis?


Osteoarthritis typically occurs in those older than age 40 years and has few signs of inflammation on examination, thus the joints are not hot, red, or tender like in the other four types of arthritis listed earlier. Look for Heberden nodes (visible and palpable distal interphalangeal [DIP] joint osteophytes; Fig. 35-2) and Bouchard nodes (proximal interphalangeal [PIP] joint osteophytes), worsening of symptoms after use and in the evening, bony spurs, and increasing incidence with age. Treat with weight reduction and as-needed nonsteroidal antiinflammatory drugs (NSAIDs) or acetaminophen.


image
Figure 35-2 Osteoarthritic hands with Heberden (distal interphalangeal) and Bouchard (proximal interphalangeal) nodes on both index fingers and thumbs. See Plate 67. (From Canale ST, Beaty JH. Campbell’s operative orthopaedics. 11th ed. Philadelphia: Mosby, 2007, Fig. 70-4.)


5 What clues point to a diagnosis of rheumatoid arthritis?


Rheumatoid arthritis often causes systemic symptoms (fever, malaise, subcutaneous nodules, pericarditis, pleural effusion, uveitis), prolonged morning stiffness, and swan neck and boutonnière deformities. The diagnosis is often made by an elevated sedimentation rate or C-reactive protein (CRP) and positive rheumatoid factor, which is present in most adults but often negative in children. Radiographs and magnetic resonance imaging (MRI) can also support the diagnosis. General treatment strategies reflect the fact that the destruction of affected joints caused by inflammation occurs early in the course of rheumatoid arthritis. The patient should be offered treatment with disease modifying antirheumatic drugs (DMARDs) as soon as possible after the onset of disease. Escalate the intensity of treatment until synovitis and inflammation have improved.


There are five general classes of medications used for the treatment of rheumatoid arthritis, with DMARDs forming the backbone of treatment. Treatment options include the following: analgesics (from acetaminophen to narcotics), NSAIDs, glucocorticoids, nonbiologic DMARDs (methotrexate, sulfasalazine, leflunomide, hydroxychloroquine, and minocycline), and biologic DMARDs. Biologic DMARDs include tumor necrosis factor (TNF) inhibitors (etanercept, infliximab, and adalimumab), an interleukin-1 receptor antagonist (anakinra), a monoclonal antibody (rituximab), and biologic response modifiers (abatacept).





Apr 8, 2017 | Posted by in NURSING | Comments Off on Rheumatology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access